Stocks Health care PSNL
NASDAQ · Health carePersonalis, Inc. (PSNL)
Personalis, Inc. brought in $80.8M of revenue over the twelve months to September 30, 2026, up 16.9% from a year earlier. It posted a net loss of $119.3M. In fiscal 2025 capital spending exceeded operating cash flow by $79.5M. At September 30, 2026 it held $98.3M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 4, 2026.
Key facts about Personalis, Inc.
- Net worth
- Personalis, Inc. has a market value (market cap) of $1.7B at the latest share price, and shareholders' equity of $212.7M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $69.6M (-17.7% year on year), with a net loss of $81.3M. Over the 12 months to September 30, 2026: revenue $80.8M, net loss $119.3M.
- Cash flow
- In fiscal 2025 operations used $74.9M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 4, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Personalis, Inc.'s next report is expected around January 15, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Personalis, Inc. does
Personalis, Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker PSNL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $69.6M | -$81.3M | -$0.91 | -$79.5M |
| 2024 | $84.6M | -$81.3M | -$1.37 | -$46.8M |
| 2023 | $73.5M | -$108.3M | -$2.25 | -$67.2M |
| 2022 | $65M | -$113.3M | -$2.48 | -$120.1M |
| 2021 | $85.5M | -$65.2M | -$1.49 | -$81.9M |
| 2020 | $78.6M | -$41.3M | -$1.20 | -$45.9M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where PSNL ranks in Health care
Latest SEC filings
What Personalis, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 6, 2026Form 425 filing 425
- November 4, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 77% to $25.6M versus the same quarter last year; diluted EPS -$0.32 versus -$0.24.
- November 4, 2026
- November 3, 2026Form 425 filing 425
- October 30, 2026Form 425 filing 425
- October 21, 2026Merger proxy statement DEFM14A
- October 21, 2026Form 425 filing 425
- October 20, 2026Form 425 filing 425
- October 20, 2026Form SC 13E3/A filing SC 13E3/A
- October 6, 2026Form 425 filing 425
Insider trades
What the people running Personalis, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $728.9K worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 3, 2026 | Hall Christopher MChief Executive Officer, Director | Sold | 29,112 | $462K |
| September 18, 2026 | Tachibana AaronCFO AND COO | Sold | 2,931 | $47.5K |
| September 18, 2026 | Hall Christopher MChief Executive Officer, Director | Sold | 7,459 | $121K |
| September 18, 2026 | Chen RichardPresident and CMO | Sold | 3,998 | $64.8K |
| September 18, 2026 | Moore Stephen MichaelSVP and Chief Legal Officer | Sold | 2,068 | $33.5K |
| July 15, 2026 | Chen RichardPresident and CMO | Exercised options | 100,000 | $244K |
| July 15, 2026 | Chen RichardPresident and CMO | Soldpre-planned (10b5-1) | 100,000 | $1.5M |
| July 9, 2026 | Hall Christopher MChief Executive Officer, Director | Exercised options | 100,000 | $161K |
Who owns PSNL
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Ravi Mhatre13D, may seek influence with 14 related filers | 15.71% | June 28, 2024 |
| ARK Investment Management LLC13G, passive with 1 related filers | 8.14% | May 14, 2025 |
Largest institutional holders
Insiders
10 insiders reported holding 798,039 shares in total, about $12.6M at the last price.
| Holder | Shares |
|---|---|
| Hall Christopher MChief Executive Officer, Director | 199,415 |
| Tachibana AaronCFO AND COO | 195,902 |
| Chen RichardPresident and CMO | 169,882 |
| Moore Stephen MichaelSVP and Chief Legal Officer | 90,257 |
| Shoff LonnieDirector | 37,190 |
| Myers Woodrow A JrDirector | 32,366 |
| Bloom Olivia KyusukDirector | 27,265 |
| Eastham KarinDirector | 19,756 |
| Bowman A BlaineDirector | 19,756 |
| Widder Kenneth JDirector | 6,250 |
Questions about PSNL
What does Personalis, Inc. do?
Personalis, Inc. is a company in the Health care sector, listed on NASDAQ as PSNL. Its shares trade on NASDAQ under the ticker PSNL.
What is Personalis, Inc.'s net worth?
Personalis, Inc. has a market value (market cap) of $1.7B at the latest share price, and shareholders' equity of $212.7M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Personalis, Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $119.3M on revenue of $80.8M.
How much revenue does Personalis, Inc. make?
Over the twelve months to September 30, 2026 Personalis, Inc. reported revenue of $80.8M. That is 16.9% more than a year earlier.
When did Personalis, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 4, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the form 425 filing from November 6, 2026.
When is Personalis, Inc.'s next earnings report?
Personalis, Inc.'s next report is expected around January 15, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare PSNL with
Follow PSNL
Get an email when Personalis, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Personalis, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.